Daily Reporter

Refine search

Date

Any time

This month

This year

Before this year

15 results for ""

Sort by

Cancer Research

What would have been unthinkable before became feasible in the interest of patient safety

Temporary accommodations made to weather the COVID-19 pandemic could accelerate lasting reform of clinical trial methodology.

20 Oct 2020

Cancer in Special Situations/ Populations

Young oncologists in the coronavirus crisis: a learning opportunity

Despite some share the concern of having their career plans delayed or disrupted by the pandemic, the new challenges emerged in these unprecedented times represent a unique opportunity to grow-up as oncology professionals and get ready to a new scenario where team working, humanisation of care and virtual education will be more crucial than ever.

20 Oct 2020

Cancer Control Principles

Telemedicine: the good and bad of living a hype

New forms of remote cancer care services have been piloted since the COVID-19 outbreak to offer support to patients while complying with hospital visiting restrictions. Despite a renewed popularity of telemedicine, digital services implemented so quickly may increase the risk of unmet expectations in the future.

20 Oct 2020

Cancer in Special Situations/ Populations

Patients with cancer and research: will COVID-19 further damage opportunities to join experimental trials?

Patients are missing out on potentially lifesaving clinical trials, but the pandemic era could be the trigger for a much-needed change in practice, says Dr Bettina Ryll, Founder of the Melanoma Patient Network Europe.

20 Oct 2020

Cancer in Special Situations/ Populations

How to make the right therapeutic choice for cancer patients at a time of crisis

According to Prof. Alberto Sobrero the most effective anticancer treatment is not always the right choice, and safely reducing treatment doses and duration is worthwhile when considered in keeping with patient values.

20 Oct 2020